Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
$3.29
+0.3700 ( +12.67% ) 1.8K
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Data
Open
$3.29
Previous close
$2.92
Volume
1.8K
Market cap
$7.37M
Day range
$2.79 - $3.18
52 week range
$1.75 - $5.25
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 14, 2024 |
10-q | Quarterly Reports | 62 | May 07, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
8-k | 8K-related | 13 | Apr 18, 2024 |
3 | Insider transactions | 1 | Mar 11, 2024 |
10-k | Annual reports | 96 | Mar 05, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
4 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Dec 11, 2023 |
3/a | Insider transactions | 1 | Dec 07, 2023 |